COM:IMPELPHARMA
Impel Pharmaceuticals Inc.
- Stock
Last Close
0.06
20/12 20:58
Market Cap
956K
Beta: -
Volume Today
720.03K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | 1.41M - | 5.63M 298.41% | |||
average payables | 3.52M - | 5.34M 51.74% | 6.23M 16.65% | ||
average receivables | 215K - | 790.50K 267.67% | 4.40M 456.36% | ||
book value per share | -6.98 - | -10.16 45.58% | 3.60 135.39% | -1.88 152.37% | |
capex per share | -0.12 - | -0.14 17.01% | -0.03 79.40% | -0.06 110.18% | |
capex to depreciation | -2.11 - | -1.65 21.56% | -0.38 77.34% | -1.15 205.75% | |
capex to operating cash flow | 0.04 - | 0.05 8.96% | 0.01 86.48% | 0.01 139.19% | |
capex to revenue | -0.61 - | -0.11 82.18% | |||
cash per share | 2.82 - | 0.54 80.82% | 6.04 1,018.85% | 2.59 57.18% | |
days of inventory on hand | 1.49K - | 473.57 68.25% | |||
days payables outstanding | 3.36K - | 342.35 89.82% | |||
days sales outstanding | 738.74 - | 214.75 70.93% | |||
debt to assets | 0.70 - | 0.30 56.88% | 0.58 92.18% | ||
debt to equity | -0.06 - | 0.56 990.21% | -1.16 306.68% | ||
dividend yield | |||||
earnings yield | -0.21 - | -0.23 9.41% | -0.61 161.39% | -1.47 142.38% | |
enterprise value | 160.08M - | 198.40M 23.94% | 67.24M 66.11% | 78.45M 16.68% | |
enterprise value over ebitda | -3.92 - | -4.48 14.38% | -0.94 79.02% | -0.94 0.27% | |
ev to operating cash flow | -4.39 - | -5.06 15.41% | -1.01 79.99% | -0.84 17.31% | |
ev to sales | 100.66 - | 6.20 93.84% | |||
free cash flow per share | -2.89 - | -3.12 7.77% | -4.57 46.68% | -4.05 11.38% | |
free cash flow yield | -0.19 - | -0.21 7.77% | -0.53 154.95% | -1.08 103.94% | |
graham net net | -7.37 - | -10.53 42.84% | 3.10 129.43% | -2.66 185.71% | |
graham number | 22.37 - | 28.23 26.20% | 20.60 27.04% | 15.30 25.73% | |
income quality | 0.87 - | 0.86 1.85% | 0.87 1.35% | 0.88 1.58% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -6.01 - | ||||
interest debt per share | 0.64 - | 2.02 215.09% | 2.77 37.49% | ||
inventory turnover | 0.24 - | 0.77 214.99% | |||
invested capital | -0.06 - | 0.56 990.21% | -1.16 306.68% | ||
market cap | 197.08M - | 197.08M 0% | 126.00M 36.07% | 87.92M 30.22% | |
net current asset value | -94.44M - | -137.39M 45.47% | 49.17M 135.79% | -52.90M 207.58% | |
net debt to ebitda | 0.91 - | -0.03 103.28% | 0.82 2,864.40% | 0.11 86.15% | |
net income per share | -3.19 - | -3.49 9.41% | -5.24 50.39% | -5.52 5.32% | |
operating cash flow per share | -2.78 - | -2.98 7.39% | -4.55 52.42% | -3.99 12.13% | |
payables turnover | 0.11 - | 1.07 882.37% | |||
receivables turnover | 0.49 - | 1.70 244.00% | |||
research and ddevelopement to revenue | 30.78 - | 0.91 97.06% | |||
return on tangible assets | -0.99 - | -3.80 283.47% | -0.78 79.42% | -1.46 87.00% | |
revenue per share | 0.05 - | 0.54 1,079.49% | |||
roe | 0.46 - | 0.34 24.84% | -1.46 524.89% | 2.93 301.11% | |
roic | 0.45 - | 0.36 20.10% | -0.87 340.67% | -9.99 1,044.77% | |
sales general and administrative to revenue | 76.20 - | 6.16 91.92% | |||
shareholders equity per share | -6.98 - | -10.16 45.58% | 3.60 135.39% | -1.88 152.37% | |
stock based compensation to revenue | 4.69 - | 0.41 91.24% | |||
tangible asset value | -91.70M - | -133.50M 45.58% | 52.51M 139.33% | -44.16M 184.10% | |
tangible book value per share | -6.98 - | -10.16 45.58% | 3.60 135.39% | -1.88 152.37% | |
working capital | 31.20M - | -2.35M 107.54% | 78.62M 3,439.93% | 57.65M 26.68% |
All numbers in (except ratios and percentages)